Form D · Biotechnology
Crinetics Pharmaceuticals, Inc.
San Diego, CA · CIK 0001658247
Offering snapshot reported Mar 11, 2024 · SEC filing
- Reported sold
- $350M Offering amount: $350M
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 1, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 11, 2024 | Initial | $350,000,028 | No comparison | 36 | SEC filing |
| Feb 23, 2018 | Initial | $59,999,999 | No comparison | 12 | SEC filing |
| Nov 16, 2015 | Initial | $18,000,001 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $14M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-507240
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| LEERINK PARTNERS LLC | 39011 | |
| PIPER SANDLER & CO. | 665 | |
| ROBERT W. BAIRD & CO. INCORPORATED | 8158 | |
| CITIZENS JMP SECURITIES, LLC | 22208 | |
| H.C. WAINWRIGHT & CO., LLC | 375 | |
| LIFESCI CAPITAL, LLC | 168404 |
Source: Form D, filed Mar 11, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Camille Bedrosian, M.D. | Director |
| Stephen Betz | Executive |
| Rogerio Vivaldi Coelho, M.D. | Director |
| Caren Deardorf | Director |
| Mason Freeman | Director |
| Mason Freeman, M.D. | Director |
| Matthew Fust | Director |
| James Hassard | Executive |
| Steve Kaldor | Director |
| Steve Kaldor, Ph.D | Director |
| Jeff Knight | Executive |
| Weston Nichols, Ph D | Director |
| Weston Nichols, Ph.D | Director |
| Jack B. Nielsen | Director |
| Stephanie Okey | Director |
| Dana Pizzuti | Executive |
| Mahendra Shah | Director |
| Richard Scott Struthers | Director, Executive |
| Richard Scott Struthers, Ph D | Director, Executive |
| Richard Scott Struthers, Ph.D | Director, Executive |
| Wendell Wierenga | Director |
| Wendell Wierenga, Ph D | Director |
| Wendell Wierenga, Ph.D | Director |
| Marc Wilson | Executive |
| Yun Fei Zhu | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6055 Lusk Boulevard
San Diego, CA, 92121
San Diego, CA, 92121